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Interactions between selective factors (hypertension and tuberculosis) and environmental effects (vitamin D deﬁciency [VDD], temperature,
and altitude) largely explain cystic ﬁbrosis (CF) carrier geography. For VDD sequelae such as hypertension and tuberculosis vulnerability, clinical
evidence of carrier protection is supported by indications that decreased CF arylsulfatase B activity suppresses tuberculosis, and that excess CF salt
loss decreases blood pressure. A need for salt retention in the tropics selected against CF carriers despite possible advantages against cholera, typhoid,
and other factors, but salt retention was less important elsewhere. Increased hypertension with cold selected for carriers with increasing latitude, and
with altitude, where hypertensive complications of pregnancy also rise.ΔF508 rates especially seem to follow these parameters, andmay be particularly
protective against hypertension, while lower rates in Ashkenazi Jews are consistent with a greater role for tuberculosis in this group. This scenario
suggests geographical correlations of CF with other genes affecting blood pressure, and signiﬁcant carrier levels, especially ofΔF508, in mountainous
areas of Asia with VDD.
© 2011 European Cystic Fibrosis Society. Published by Elsevier B.V. All rights reserved.Keywords: cystic ﬁbrosis; heterozygotic advantage; vitamin D deﬁciency; tuberculosis; hypertension; delta F508; altitude; temperature.CF carrier rates of 4% ormore despite traditional homozygotic
lethality suggest heterozygotic advantages, with relatively high,
intermediate, and low to negligible frequencies in different areas
supporting differences in selection. A variety of mechanisms
have been proposed [1-3], and resistance to tuberculosis seems
well supported [1]. However, evidence exists for more complex
interactions of vitamin D deficiency (VDD) with tuberculosis
and hypertension, and altitude and temperature with hypertension
alone.
Overall, a role for VDD has two lines of support:
First, CF heterozygosity generally correlates with past areas
of VDD, one of the great selective pressures on Caucasians [4].
Relative frequencies are low in Eskimos, where diet was ade-
quate; elsewhere, skin production from ultraviolet light, whose
intensity is inversely related to latitude, is generally crucial,⁎ Tel.: +1 414 702 9579.
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where light skin, which increases ultraviolet absorption, reflects
VDD related selection. Skin exposure, influenced by tempera-
ture, season, and cultural factors, also has an effect, with interme-
diate carrier rates in Moslem areas with VDD secondary to
culturally decreased exposure [4, 5].
Second, while CFTR doesn't seem to directly affect vitamin
D metabolism [6], mutations can mitigate at least two deficiency
sequelae: Tuberculosis susceptibility and hypertension.
Clinical findings of tuberculosis vulnerability with VDD are
supported by laboratory evidence of a role for vitamin D in sup-
pressing and killing mycobacteria [6, 7]. At the same time,
clinical observations of tubercular protection in CF homo- and
hetero- zygotes are supported by indications that decreased CFs
arylsulfatase B activity reduces sulfate availability for mycobac-
terial cell wall synthesis [8].
With this, European CF heterozygosity has been epidemio-
logically linked to a tuberculosis pandemic from the early 17thby Elsevier B.V. All rights reserved.
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a role here: Cold, a major VDD risk factor, was the worst in the
millennium in the 17th century, and climate change devastated
fisheries for cod, a good source of vitamin D [9], possibly
exacerbating deficiencies.
However, high carrier rates with altitude (Table 1) despite
decreased tuberculosis [10], and intermediate heterozygosity
without past pandemics, as in the Middle East [11], suggest
additional factors. Hypertension is a good candidate: VDD in-
creases blood pressure [12] and interacting obstetrical prob-
lems [13], while systemic blood pressure decreases with CF,
possibly from increased sweat sodium loss [14], and carriers,
especially women, had lower blood pressure [15]. Less inher-
ited hypertension in whites than blacks [16, 17] is also consis-
tent with selection against high blood pressure in areas of past
VDD.
A possible exception to a VDD/carrier correlation is high
heterozygosity with altitude despite greater ultraviolet light,
although other factors can still lead to VDD here [18]. However,
hypertensive complications of pregnancy rise with altitude [19],
and cold increases blood pressure [20], maintaining significant
selection in such areas even without any contribution from VDD.
ΔF508, the most common CF allele [2], may be especially
selected for here, following cooler temperatures with an in-
creasing Southeast to Northwest European frequency [2, 21],
as well as altitude (Table 1, and possibly Baluchistan [3]).
Supporting a link to hypertension, other salt regulating genes
also correlate with latitude, and with altitude, as with Basques
[22, 23]. Contrariwise, relatively low ΔF508 rates in Ashkenazi
Jews [2] are consistent with a greater role for selection against
tuberculosis in this group [24].
Together, these factors help explain most of the geography
of CF carriers:
1. Protection from tropical factors such as typhoid fever can
favor certain metabolically neutral CFTR polymorphisms
[25, 26]. However, heterozygous CF alleles can cause salt
losses [27], and, even when similarly protective, were elim-
inated in these areas by a need for retention in the face of
heat losses [15].Table 1
Prevalence of CF and Δf508 Carriers at High Altitudes⁎ and Adjacent Areas.
Area ΔF508% ΔF508 carriers per 1000
people (calculated)
CF prevalence
(Births for 1 case)
Austria (total) [2, 28] 62.9 10.6 3500
⁎Austria (Tyrol) [2] 74.6
⁎Switzerland [2] 57.2 12.8 2000
Italy [2, 25] 49.0 7.5 4238
⁎Albania (émigrés)
[29]
75.0 31.2 555
France [2, 24] 67.7 9.9 4700
⁎Basque Country
[23]
87.0 13.0 4500
Spain [2, 24] 52.7 8.6 3750
Note: Comparisons are complicated by a decreasing Northwest-Southeast frequency
gradient [2].2. Outside of the tropics, VDD from decreased light selected
for greater Vitamin D production and for amelioration of
VDD effects, while selection for salt retention was relaxed
or reversed [15].
3. Hypertension associated with VDD and with salt retention in
non-tropical areas selected for CF and other mitigating genes
affecting sodium metabolism.
4. Worsening of VDD and hypertension with cold resulted in a
CF temperature/latitude gradient.
5. While VDD could decrease with altitude, blood pressure
remained an important selective force at high elevations be-
cause of greater hypertensive mortality with cold and/or
altitude.
6. VDD related susceptibility to tuberculosis helped define the
scope and timing of a European pandemic that began in the
17th century.
7. Tuberculosis subsequently selected for CF carrier protection
in that same area.
8. Different CF alleles may have different protective effects:
ΔF508 associates with areas of hypertensive risk, while
others are more linked to tuberculosis. Alleles effective
against typhoid, cholera, and other factors [26] may also
have had a role in certain non-tropical areas.
This scenario suggests geographical correlations of CF with
other, especially salt related, genes affecting hypertension, and
significant carrier levels, especially for ΔF508, in mountainous
areas of Asia with VDD [18]. Better world-wide statistics are
needed, correlated with estimates of historic VDD.
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